A translational framework to DELIVER nanomedicines to the clinic

Paul Joyce(University of South Australia), Christine Allen(University of Toronto), Marı́a José Alonso(Universidade de Santiago de Compostela), Marianne Ashford(AstraZeneca (United Kingdom)), Michelle S. Bradbury(Cornell University), Matthieu Germain(Nanobiotix (France)), Maria Kavallaris(Cancer Institute of New South Wales), Róbert Langer(Massachusetts Institute of Technology), Twan Lammers(Düsseldorf University Hospital), Maria Teresa Peracchia(Sanofi (France)), Amirali Popat(The University of Queensland), Clive A. Prestidge(University of South Australia), Cristianne J.F. Rijcken(Cristal Therapeutics (Netherlands)), Bruno Sarmento(Universidade do Porto), Ruth Schmid(SINTEF), Avi Schroeder(Technion – Israel Institute of Technology), Santhni Subramaniam(University of South Australia), Chelsea R. Thorn(Pfizer (United States)), Kathryn A. Whitehead(Carnegie Mellon University), Chun‐Xia Zhao(The University of Queensland), Hélder A. Santos(University Medical Center Groningen)
Nature Nanotechnology
September 6, 2024
Cited by 207Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis